Epirium Bio, Inc
Epirium Bio, Inc is a biopharmaceutical company based in San Diego, California, that specializes in developing innovative therapeutics targeting muscle biology, tissue regeneration, and mitochondrial function. With a focus on addressing high unmet medical needs, Epirium Bio leverages its deep understanding of these areas to develop potential therapies with broad clinical applicability across multiple disease areas.
Founded in 2008, Epirium Bio has a rich history of scientific advancements, including the discovery of -epicatechin and its association with trophic effects on mitochondrial function and density. Under the leadership of its experienced team, the company has conducted successful clinical trials and obtained critical patents for its novel chemical entities. Currently, Epirium Bio is actively engaged in a Phase 1 clinical trial for Becker muscular dystrophy, evaluating the safety and efficacy of its synthetic compound, EPM-01, which has shown promise in preclinical and clinical studies of mitochondrial dysfunction.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
